Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML

NCT00538876 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: decitabine

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]